![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Arai, M Kessler, G Rogers and G Lynch
Center for the Neurobiology of Learning and Memory, University of California, Irvine, USA.
The benzoylpiperidine drug BDP-12 (1-(quinoxalin-6- ylcarbonyl)piperidine) enhances the encoding of transient and stable forms of memory by rats. Results reported here show that the drug increases fast, excitatory (glutamatergic) synaptic responses in hippocampal slices by about 50% with an EC50 of 170 microM. Analyses with polysynaptic responses indicated that the drug has a facilitatory action at concentrations as low as 12.5 microM. BDP-12 at 1 mM did not change the resting membrane potential, input resistance or spiking threshold and it did not alter monosynaptic potentials mediated by gamma-aminobutyric acid (GABA) receptors; it did, however, enhance disynaptic inhibitory responses. In membrane patches excised from hippocampal neurons, BDP-12 at moderate concentrations (50 microM) increased the steady-state currents mediated by DL-alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and slowed the rate at which the receptors desensitize, with a much larger effect on the former; the drug delayed the closing of the AMPA receptor channel after 1-msec agonist pulses. BDP-12 had no detectable effect on [3H]AMPA binding affinity. A related and more potent analog produced a different pattern of results in that it had about equal effects on steady-state currents and desensitization rates and significantly increased binding to AMPA receptors. These results indicate that the benzoylpiperidine family of modulators has functionally distinct subclasses. The findings also establish that BDP-12: 1) enhances synaptic responses in the same concentration range at which it alters AMPA receptor kinetics, 2) has a lower apparent threshold for effects on complex network operations than on monosynaptic transmission, 3) does not directly influence inhibitory responses and 4) is likely to modulate AMPA receptors on interneurons as well as on pyramidal neurons.
This article has been cited by other articles:
|
|
 |
|
  R. Jin, S. Clark, A. M. Weeks, J. T. Dudman, E. Gouaux, and K. M. Partin Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors J. Neurosci., September 28, 2005; 25(39): 9027 - 9036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S.F. Ling and L. S. Benardo Nootropic Agents Enhance the Recruitment of Fast GABAA Inhibition in Rat Neocortex Cereb Cortex, July 1, 2005; 15(7): 921 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-F. Xia, M. Kessler, and A. C. Arai Positive {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Modulators Have Different Impact on Synaptic Transmission in the Thalamus and Hippocampus J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 277 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Lauterborn, G. S. Truong, M. Baudry, X. Bi, G. Lynch, and C. M. Gall Chronic Elevation of Brain-Derived Neurotrophic Factor by Ampakines J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 297 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Leever, S. Clark, A. M. Weeks, and K. M. Partin Identification of a Site in GluR1 and GluR2 That Is Important for Modulation of Deactivation and Desensitization Mol. Pharmacol., July 1, 2003; 64(1): 5 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Arai, Y.-F. Xia, G. Rogers, G. Lynch, and M. Kessler Benzamide-Type AMPA Receptor Modulators Form Two Subfamilies with Distinct Modes of Action J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1075 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Arai, Y.-F. Xia, M. Kessler, D. Phillips, R. Chamberlin, R. Granger, and G. Lynch Effects of 5'-Alkyl-Benzothiadiazides on (R,S)-alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Biophysics and Synaptic Responses Mol. Pharmacol., September 1, 2002; 62(3): 566 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Menniti, B. L. Chenard, M. B. Collins, M. F. Ducat, M. L. Elliott, F. E. Ewing, J. I. Huang, K. A. Kelly, J. T. Lazzaro, M. J. Pagnozzi, et al. Characterization of the Binding Site for a Novel Class of Noncompetitive alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists Mol. Pharmacol., April 13, 2001; 58(6): 1310 - 1317. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. Hodgkiss and J. S. Kelly Effect of FK960, a Putative Cognitive Enhancer, on Synaptic Transmission in CA1 Neurons of Rat Hippocampus J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 620 - 628. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Arai, M. Kessler, G. Rogers, and G. Lynch Effects of the Potent Ampakine CX614 on Hippocampal and Recombinant AMPA Receptors: Interactions with Cyclothiazide and GYKI 52466 Mol. Pharmacol., October 1, 2000; 58(4): 802 - 813. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Lauterborn, G. Lynch, P. Vanderklish, A. Arai, and C. M. Gall Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons J. Neurosci., January 1, 2000; 20(1): 8 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Johnson, N. T. Luu, T. A. Herbst, R. Knapp, D. Lutz, A. Arai, G. A. Rogers, and G. Lynch Synergistic Interactions between Ampakines and Antipsychotic Drugs J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 392 - 397. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Holst, P. W. Vanderklish, L. A. Krushel, W. Zhou, R. B. Langdon, J. R. McWhirter, G. M. Edelman, and K. L. Crossin Allosteric modulation of AMPA-type glutamate receptors increases activity of the promoter for the neural cell adhesion molecule, N-CAM PNAS, March 3, 1998; 95(5): 2597 - 2602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Rogan, U. V. Staubli, and J. E. LeDoux AMPA Receptor Facilitation Accelerates Fear Learning without Altering the Level of Conditioned Fear Acquired J. Neurosci., August 1, 1997; 17(15): 5928 - 5935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Impagnatiello, A. Oberto, P. Longone, E. Costa, and A. Guidotti 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide: A partial modulator of AMPA receptor desensitization devoid of neurotoxicity PNAS, June 24, 1997; 94(13): 7053 - 7058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Staubli and J. Scafidi Studies on Long-Term Depression in Area CA1 of the Anesthetized and Freely Moving Rat J. Neurosci., June 15, 1997; 17(12): 4820 - 4828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U Staubli and D Chun Proactive and retrograde effects on LTP produced by theta pulse stimulation: mechanisms and characteristics of LTP reversal in vitro. Learn. Mem., January 1, 1996; 3(2-3): 96 - 105. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
